|
We are currently finalizing the 2009 conference programme. Below you will find the 2008 programme for your persual.
Middle East Laboratory Management
And Medicine Conference
28 - 31January 2008
Track A - Laboratory Management
Monday, 28 January 2008 |
| |
| Registration will be open from 7.30am |
| |
| 10.00 |
Opening remarks
Chair: Dr Najat Rashid, Director of Medical Laboratories
Ministry of Health, UAE
|
| |
|
| 10.10 |
Standards in medical laboratories as a driver in clinic care
Dr Robin Pavillard, Executive Director, Quality
Healthcare Australia Pty. Ltd, Victoria, Australia and representing the Australian Council on Healthcare Standards
|
| |
|
| 10.50 |
ISO 15189 accreditation - a view from and for the medical laboratory
Dr Lorenz Leitritz, Medical Director Microbiology
Bioscientia, Ingelheim, Germany |
| |
|
| 11.30 |
Break
|
| |
|
| 12.00 |
Options in accreditation - a comparison of ISO, CAP, and JCI accreditation standards and survey process, strengths and challenges with each option
Maureen Connors Potter, BSN MSN,
Vice President for International Services
The Greeley Company, HCPro, USA
|
| |
|
| 12.45 |
Benchmarking quality assurance and proficiency testing in medical laboratories
Andy Saleh BA, BSc, MT(ASCP), Certified CAP
Inspector, Chief Quality Officer (CQO)
MedLabs Consultancy Group, Amman, Jordan
|
| |
|
| 13.30 |
Lunch break |
| |
|
| 14.15 |
External quality assessment and laboratory accreditation
Dr Ian Gardner, RCPA QAP Chief Executive
RCPA Quality Assurance Programs Pty Limited, NSW,Australia
|
| |
|
| 14.50 |
Case study: total laboratory automation and quality improvement in relation to lean 6 Sigma concepts
Andrew Turner, Laboratory Manager and
Dr Laila Abdel-Wareth, Chair, Laboratory Medicine
Sheikh Khalifa Medical City, Abu Dhabi, UAE
|
| |
|
| 15.30 |
Total quality management and laboratory automation - a perspective from Europe
Dr Claudio Rieppi, Chief, Clinical Laboratory
Hospital of Monfalcone, Italy |
| |
|
| 16.10 |
Short break |
| |
|
| 16.20 |
Round table discussion: assessing the present state of laboratory accreditation in the Middle East and what will be needed for the future
|
| |
|
| 17:15 |
Close
|
| |
|
| |
|
Track B - Molecular Diagnosis
Tuesday, 29 January 2008 |
| |
| Registration will be open from 7.30am |
| |
| 09.40 |
Opening remarks
Chair: Dr Sabita Murthy, Consultant Geneticist, Head, Molecular Cytogenetics Unit
Genetics Department, Al Wasl Hospital, Dubai, U.A.E.
|
| |
|
| 09.45 |
Syndromic approach to the diagnosis of infections of eye and brain
Dr. BV Ravi Kumar, MBBS,PhD, Managing Director,
XCyton Diagnostics Limited, Bangalore, India
|
| |
|
| 10.00 |
Cystic fibrosis and thalassaemia mutations analysis using oligoarray and hair loop method
Dr Moncef BenKhalifa, Director, ATL R&D. Reproductive Biology & Genetics Laboratory, Paris, France and Scientific Consultant, Reproductive Medicine & Genetics, Unilabs Laboratories, Geneva, Switzerland
|
| |
|
| 10.45 |
Screening of HPV in women for cancer prevention
Dr Jörg Stappert, Greiner Bio-One, Vienna, Austria
|
| |
|
| 11.15 |
Break
|
| |
|
| 11.45 |
Breast cancer and the latest FISH (fluorescence in situ hybridisation) techniques
Dr Sabita Murthy, Consultant Geneticist, Head, Molecular Cytogenetics Unit
Genetics Department, Al Wasl Hospital, Dubai, U.A.E.
|
| |
|
| 12.15 |
Application of quantitative fluorescent PCR for aneuploidy and microdeletion syndrome screening
Dr Moncef BenKhalifa, Director, ATL R&D. ReproductiveBiology & Genetics Laboratory, Paris and Scientific Consultant, Reproductive Medicine & Genetics, Unilabs Laboratories, Geneva, Switzerland
|
| |
|
| 13.00 |
Lunch Break
|
| |
|
| 14.15 |
Development of a novel quantitative real-time RT-PCR assay for the measurement of HIV-1 plasma virus load
Dr Pradeep Seth, Consultant: Research & Academics
Dr. Lal Pathlabs Pvt. Ltd. New Delhi |
| |
|
| 14.45 |
Genetic diagnostics of myeloproliferative diseases
Prof Jochen Decker, Bioscientia, Ingelheim, Germany |
| |
|
| 15.30 |
Break |
| |
|
| 16.00 |
New trends in the earlty detection of urinary tract malignancy
Dr Saad Baher Elbadawi, Laboratory Director, Erfan & Bagedo Hospitals, Jeddah, KSA |
| |
|
| 16.30 |
Target and Biomarker Discovery using Microarrays and Whole Genome Approaches
Mohammad Jaber, Genomics Product Specialist, Gulf Scientific Corporation, Dubai, UAE |
| |
|
| 17.15 |
Close |
| |
|
| |
|
Track C - Microbiology/Immunology
Wednesday, 30 January 2008 |
| |
| Registration will be open from 7.30am |
| |
| 09.50 |
Opening remarks
Chair: Dr Mansour Al-Zarouni, Head of Laboratories, Sharjah Medical District, Ministry of Health, UAE |
| |
|
| 10.00 |
Multi-drug resistance TB infection – a South East Asian perspective
Prof Digamber Behera, Director, LRS Institute of Tuberculosis and Chest Diseases, New Delhi, India |
| |
|
| 10.30 |
Vancomycin-resistant enterococci and methycillin-resistant Staphylococcus aureus
Dr Mansour Al-Zarouni, Medical & Molecular Microbiologist, Head of Laboratories, Sharjah Medical District, Ministry of Health, UAE |
| |
|
| 11.00 |
Diagnosis and treatment of childhood tuberculosis
Dr Vas Novelli, Great Ormond Street Hospital, London, UK |
| |
|
| 11.30 |
Break |
| |
|
| 11.50 |
Functional and phenotypical distinct subsets of natural killer cells
Dr. Günnur Deniz, Professor, Immunology Department, University of Istanbul, Turkey |
| |
|
| 12.20 |
Infections in the immunocompromised child
Dr Vas Novelli, Great Ormond Street Hospital, London, UK |
| |
|
| 12.50 |
A novel diagnostic test for TB
Dr Peter Wrighton-Smith, Chief Executive Officer, Oxford Immunotec, UK |
| |
|
| 13.20 |
Lunch break |
| |
|
| 14.30 |
Nosocomial candida infections in a special care unit
Prof Arunaloke Chakrabarty, Professor In Charge,
Division of Mycology, Department of Medical Microbiology
Postgraduate Institute of Medical Education & Research,
Chandigarh, India |
| |
|
| 15.00 |
Multicenter evaluation of a new anti-HCV immunoassay
Professor Dr Bernard Weber, Laboratoires Réunis, Junglinster, Luxembourg |
| |
|
| 15.30 |
Break |
| |
|
| 15.50 |
Allergy diagnosis in clinical practice
Professor Khamis Gomaa, Professor of Clinical Pharmacology of Allergy and Immunology, Faculty of Medicine, Alexandria University, Eygpt |
| |
|
| 16.20 |
Campylobacter enteritis: a perspective from the Gulf region
Dr Abiola Senok, College of Medicine, University of Sharjah, UAE |
| |
|
| 17.00 |
Close |
| |
|
| |
|
Track D - Clinical Chemistry
Thursday, 31 January 2008 |
| |
| Registration will be open from 7.30am |
| |
| 9.50 |
Opening remarks
Chairman: Dr Jagadesh Chakraborty, Associate Professor, Faculty of Allied Health Sciences, Health Sciences Center, Kuwait University |
| |
|
| 10.00 |
Newborn screening for errors of metabolism and genetic disorders using tandem mass spectrometry – the use of diagnostic kits in LC-MS/MS
Dr. Frank Kühlwein, International Sales Manager, Chromsystems GmbH, Germany |
| |
|
| 10.50 |
Evidence for the clinical use of tumour markers
Dr Roland Einarsson, Professor, Scientific Affairs
Fujirebio Diagnostics AB, Gothenburg, Sweden |
| |
|
| 11.20 |
Break |
| |
|
| 11.40 |
Cardiac biomarkers – current evidence based clinical uses
Dr Paul Collinson, Consultant Chemical Pathologist, Department of Chemical Pathology, St George’s Healthcare NHS Trust, London, UK |
| |
|
| 12.20 |
Innovative cardiac markers and the impact on patient management
Birgit Herzig, Product Manager Cardiac Immunoassays, Abbott Diagnostics, Germany |
| |
|
| 13.00 |
Lunch break |
| |
|
| 14.30 |
Point-of-Care Testing of NT-proBNP
Dr. Zerback, Roche Diagnostics Clinical Trials |
| |
|
| 15.00 |
Beyond LDL – what now?
Prof AO Akanji, Professor of Chemical Pathology, Health
Sciences Centre, Kuwait University, Kuwait |
| |
|
| 15.30 |
Break |
| |
|
| 15.50 |
Development of newer assays for steroid hormones
Dr Satish Chandra, Tawam Hospital, Al Ain, UAE |
| |
|
| 16.30 |
Vitamin D – the ‘sun-shine’ hormone and deficiency
Dr Afrozul Haq, Senior Clinical Scientist Laboratory Medicine, Sheikh Khalifa Medical City, Abu Dhabi, UAE |
| |
|
| 17.00 |
Close |
| |
|
| |
|
Track E - Haematology
Thursday, 31 January 2008 |
| |
| Registration will be open from 7.30am |
| |
| 9.50 |
Opening remarks
Chair: Dr Rania Seliem, Haematopathology Consultant
Head of Pathology Dept, Rashid Hospital, Dubai Health Authority, UAE |
| |
|
| 10.00 |
Banking on cord blood: the future of regenerative medicine?
Prof Colin McGuckin, Professor of Regenerative
Medicine, University of Newcastle, UK |
| |
|
| 10.45 |
Beyond hematology: cord blood stem cells for liver therapy
Dr Saba Habibollah
University of Newcastle Upon Tyne, North East England
Stem Cell institute, UK |
| |
|
| 11.15 |
Break |
| |
|
| 11.45 |
The 2007 WHO Classification updates for acute leukaemia & MDS: where are we going?
Dr. Saad Baher Elbadawi, Laboratory Director
Erfan & Bagedo Hospitals, Jeddah, KSA |
| |
|
| 12.20 |
A Preliminary Investigation into a Simple and Robust Protein Precipitation Method for the Simultaneous Determination of Immunosuppressants in Transplant Patient Blood Using LC-MS/MS
Alexandre Paccou Clinical Marketing, Waters European Headquarter, Guyancourt, France |
| |
|
| 13.00 |
Lunch break |
| |
|
| 14.15 |
Thalassaemia overview
Dr David Spence
Sheikh Khalifa Medical City, Abu Dhabi, UAE |
| |
|
| 14.45 |
Laboratory management in haematology, a workcell solution
Mick Chomyn, Assistant General Manager, Path Links Pathology Service, Lincolnshire, UK |
| |
|
| 15.30 |
Break |
| |
|
| 15.50 |
Five minutes preparation of platelet poor plasma for routine coagulation testing
Dr. Ahmad Sultan, Medical Technology Department
College of Health Sciences, University of Sharjah, Sharjah, UAE |
| |
|
| 16.20 |
Factor X-Riyadh
Dr. Akram Al-Hilali, Consultant Hematopathologist, Dubai Hospital, Dubai, UAE |
| |
|
| 16.45 |
Close |
| |
|
| |
|
| Speaker Faculty |
| |
|
Dr Mansour Al-Zarouni, Medical & Molecular Microbiologist
Head of Laboratories, Sharjah Medical District, Ministry of Health, UAE
Science Committee Chairman, MedLab
Dr Laila Abdel Wareth, Chair, Laboratory Medicine
Sheikh Khalifa Medical City, Abu Dhabi, UAE
Dr. Akram Al-Hilali, Consultant Hematopathologist
Dubai Hospital, Dubai, UAE
Prof A O Akanji, Professor of Chemical Pathology
Department of Pathology, Faculty of Medicine, Health Sciences Centre, Kuwait University
Prof Digamber Behera
Director, LRS Institute of Tuberculosis and Chest Diseases
New Delhi, INDIA
Dr Moncef BenKhalifa
ATL R&D. Reproductive Biology & Genetics Laboratory. Paris
Scientific Consultant, Reproductive Medicine & Genetics
UNILABS Laboratories. GENEVA
Prof Arunaloke Chakrabarty
Professor In Charge, Division of Mycology, Department of Medical Microbiology
Postgraduate Institute of Medical Education & Research, Chandigarh, India
Dr Jagadesh Chakraborty
Associate Professor, Faculty of Allied Health Sciences, Health Sciences Center, Kuwait University
Dr Satish Chandra
Tawam Hospital, Al Ain, UAE
Mr Mick Chomyn
Assistant General Manager, Path Links Pathology Service, Lincolnshire, UK
Dr Paul Collinson
St Georges Hospital, London
Prof Jochen Decker,
Bioscientia
Dr. Günnur Deniz, Professor
Immunology Department, University of Istanbul
Dr Saad Baher Elbadawi
Laboratory Director, Erfan & Bagedo Hospitals, Jeddah, KSA
Dr Roland Einarsson, Professor, Scientific Affairs
Fujirebio Diagnostics AB, Gothenburg, Sweden
Dr Ian Gardner, RCPA QAP Chief Executive
RCPA Quality Assurance Programs Pty Limited, NSW, Australia.
Prof Khamis Gomaa, Professor of Clinical Pharmacology of Allergy and Immunology
Faculty of Medicine, Alexandria University
Dr Saba Habibollah
University of Newcastle Upon Tyne, North East England Stem Cell institute, UK
Dr. Afrozul Haq
Senior Clinical Scientist Laboratory Medicine, Sheikh Khalifa Medical City, Abu Dhabi, UAE
Ms Birgit Herzig
Abbott Diagnostics, Germany
Dr Frank Kühlwein
International Sales Manager, Chromsystems GmbH, Germany
Dr Ajit Lalvani
Professor of Infectious Diseases, Head, Tuberculosis Immunology Group
Department of Respiratory Medicine ,National Heart and Lung Institute, Faculty of Medicine, Imperial College London, UK
Dr Lorenz Leitritz, Medical Director Microbiology
Bioscentia, Ingelheim, Germany
Prof Colin McGuckin, Professor of Regenerative Medicine
University of Newcastle, UK
Dr Sabita Murthy, Consultant Geneticist, Head, Molecular Cytogenetics Unit
Genetics Department, Al Wasl Hospital, Dubai, U.A.E.
Dr Vas Novelli
Great Ormond Street Hospital, London
Mr Alexandre Paccou
Clinical Marketing, Waters European Headquarter, Guyancourt, France
Dr Robin Pavillard, Executive Director
Quality Healthcare Australia Pty Ltd, Victoria, Australia
Ms Maureen Connors Potter, BSN, MSN, Vice President for International Services
The Greeley Company, HCPro
Dr Najed Rashid, Director of Medical Laboratories
Ministry of Health, UAE
Dr Claudio Rieppi
Chief, Clinical Laboratory, Hospital of Monfalcone, Italy
Mr Andy Saleh BA, BSc, MT(ASCP), Certified CAP Inspector, Chief Quality Officer (CQO)
MedLabs Consultancy Group, Amman, Jordan
Dr Rania Seliem, Haematopathology Consultant
Rashid Hospital, Dubai Health Authority, Dubai
Dr Abiola Senok
College of Medicine, University of Sharjah
Dr Pradeep Seth, Consultant: Research & Academics
Dr. Lal Pathlabs Pvt. Ltd. New Delhi
Dr David Spence
Sheikh Khalifa Medical City, Abu Dhabi
Dr Jörg Stappert
Greiner Bio-One, Vienna, Austria
Dr Ahmad Sultan
Medical Technology Department College of Health Sciences, University of Sharjah, Sharjah, UAE
Mr Andrew Turner, Laboratory Manager, and Dr Laila Abdel Wareth, Chair, Laboratory Medicine
Sheikh Khalifa Medical City, Abu Dhabi, UAE
Professor Dr Bernard Weber
Laboratoires Réunis, Junglinster, Luxembourg
Dr Peter Wrighton-Smith
Chief Executive Officer, Oxford Immunotec, UK
Dr Rainer Zerback
Roche Diagnostics Clinical Trials
|
 |
|
 |
|